Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Gordon

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 29, 2020
COVID-19 in Africa: preparing for the stormJ Chakaya, A Binegdie, A Irungu, et al.
Mucosal Immunology|April 30, 2015
Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriageS Glennie, J F Gritzfeld, S H Pennington, et al.
Mucosal Immunology|September 1, 2016
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriageE Mitsi, A M Roche, J Reiné, et al.
Vaccine|April 3, 2024
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisationG Tembo, M Mayuni, R Kamng'ona, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profilesB Morton, K G Barnes, C Anscombe, et al.
Vaccine|January 23, 2026
13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adultsG Tembo, D Hoving, A C de Kroon, et al.
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 29, 2020
COVID-19 in Africa: preparing for the stormJ Chakaya, A Binegdie, A Irungu, et al.
Mucosal Immunology|April 30, 2015
Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriageS Glennie, J F Gritzfeld, S H Pennington, et al.
Mucosal Immunology|September 1, 2016
Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriageE Mitsi, A M Roche, J Reiné, et al.
Vaccine|April 3, 2024
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisationG Tembo, M Mayuni, R Kamng'ona, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
In depth analysis of patients with severe SARS-CoV-2 in sub-Saharan Africa demonstrates distinct clinical and immunological profilesB Morton, K G Barnes, C Anscombe, et al.
Vaccine|January 23, 2026
13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adultsG Tembo, D Hoving, A C de Kroon, et al.
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
Pageof 5